Tag: Pharma acquisition news

Ironwood Pharmaceuticals to acquire Swiss biotech company VectivBio

businessnewstoday- May 22, 2023

Ironwood Pharmaceuticals, a gastrointestinal (GI)-focused healthcare company, has agreed to acquire VectivBio Holding AG, a Switzerland-based biotech company, listed on the Nasdaq, for around $1 ... Read More

Lupin to acquire French generics injectables developer Medisol

businessnewstoday- May 6, 2023

Indian pharma company Lupin has agreed to acquire Medisol, a French pharmaceutical company, for an undisclosed price. Established in 2011, Medisol is engaged in developing ... Read More

Astellas Pharma to acquire avacincaptad pegol developer Iveric Bio for $6bn

businessnewstoday- May 1, 2023

Japanese pharma company Astellas Pharma has agreed to acquire Nasdaq-listed Iveric Bio in an all-cash deal worth around $5.9 billion with an aim to create ... Read More

Lilly to sell hypoglycemia drug BAQSIMI to Amphastar Pharmaceuticals

businessnewstoday- April 24, 2023

Eli Lilly and Company (Lilly) has agreed to sell its severe hypoglycemia drug BAQSIMI to Amphastar Pharmaceuticals in a deal potentially worth up to $1.07 ... Read More

GSK to acquire Canadian biopharma company BELLUS Health for $2bn

businessnewstoday- April 23, 2023

GSK has agreed to acquire BELLUS Health, a Canadian biopharma company, in a deal worth around $2 billion in a move to further bolster its ... Read More

Merck to acquire biotech company Prometheus Biosciences for $10.8bn

businessnewstoday- April 16, 2023

Merck has agreed to acquire Prometheus Biosciences, a Nasdaq-listed clinical-stage biotechnology company, in an all-cash deal worth around $10.8 billion, in a move to bolster ... Read More

Eris Lifesciences strikes deal for Dr. Reddy’s cosmetic dermatology brands

businessnewstoday- March 18, 2023

Eris Lifesciences has announced the acquisition of nine cosmetic dermatology brands in the Indian market from Dr. Reddy's Laboratories for INR 275 crores in cash. ... Read More

Pfizer to acquire cancer drugmaker Seagen for $43bn in cash

Raghuram Kadari- March 16, 2023

American pharmaceutical and biotechnology company Pfizer has agreed to acquire cancer drugmaker Seagen (formerly Seattle Genetics) for $229 per share or $43 billion in cash, ... Read More

Sesen Bio gets shareholders’ approval for merger with Carisma Therapeutics

businessnewstoday- March 4, 2023

Nasdaq-listed Sesen Bio said that its stockholders have approved the previously announced merger deal with Carisma Therapeutics aimed at creating a clinical-stage biotechnology company for ... Read More

Dr. Reddy’s Laboratories to acquire Mayne Pharma’s US retail generics portfolio

businessnewstoday- February 28, 2023

Dr. Reddy's Laboratories has agreed to acquire the US generic prescription product portfolio of Mayne Pharma Group, an Australian pharma company, in a deal worth ... Read More